These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1003132)

  • 1. Current status of polio immunization, with recent legal implications.
    Van Reken DE
    J Fam Pract; 1976 Dec; 3(6):603-5. PubMed ID: 1003132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE; Abed Y; Marcus O; Gerichter CB; Melnick JL
    Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis and the control programme.
    Basu RN
    Indian J Public Health; 1985; 29(3):157-61. PubMed ID: 3835132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a program successfully combining live and killed polio vaccines.
    Lasch EE; Abed Y; Gerichter CB; Massri ME; Marcus O; Hensher R; Goldblum N
    Isr J Med Sci; 1983 Nov; 19(11):1021-3. PubMed ID: 6662685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
    Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
    Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates.
    Heymann DL; Murphy K; Brigaud M; Aymard M; Tembon A; Maben GK
    Bull World Health Organ; 1987; 65(4):495-501. PubMed ID: 3500802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polio immunization: benefits and risks.
    Wyatt HV
    J Fam Pract; 1978 Sep; 7(3):469-74. PubMed ID: 690580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(4):97-9. PubMed ID: 16456525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Poliomyelitis--why we must continue to vaccinate!].
    Windorfer A; Beyrer K
    MMW Fortschr Med; 2005 Feb; 147(8):36, 38, 40. PubMed ID: 18437859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK; Strebel PM; de Quadros CA; Olivé JM
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paralytic poliomyelitis during the pre-, peri- and post-suspension periods of a polio immunization campaign.
    Lamina S; Hanif S
    Trop Doct; 2008 Jul; 38(3):173-5. PubMed ID: 18628551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.